CONMED CNMD 深 滬
等待開盤 12-26 09:30:00 美东时间
40.17
+0.530
+1.34%
華盛通- 最 高40.36
- 今 開39.86
- 成交量 14.99万股
- 最 低 39.73
- 昨 收 39.64
- 總市值 12.44亿
- 52周最高 74.10
- 市盈率 靜 9.45
- 換手率 0.00%
- 52周最低 38.32
- 委 比 58.14%
- 總股本 3096.80万
- 歷史最高 155.91
- 量 比 0.25
- 振 幅 1.59%
- 歷史最低 11.01
- 每 手 1
- 風險率 8.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Small cap stocks poised to benefit from the Fed’s cutting cycle
BofA analysts highlighted a list of companies that historically have benefited from the Federal Reserve’s interest rate cutting cycles since 1989. These are Russell 2000 (IWM) stocks that rank highly ...
12-20 05:24
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
12-09 10:32
Conmed Intends To Exit Its Gastroenterology Product Lines As Part Of Its Broader Portfolio Optimization Strategy
Financial Considerations Related to the ExitGastroenterology product lines are expected to generate $90 million to $95 million in revenue in 2025 with gross margins of approximately 45%.As a result of this strategic
12-05 21:08
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
Wells Fargo Maintains Equal-Weight on Conmed, Lowers Price Target to $47
Wells Fargo analyst Vik Chopra maintains Conmed (NYSE:CNMD) with a Equal-Weight and lowers the price target from $57 to $47.
11-06 23:46
Conmed Narrows FY2025 Adj EPS Guidance from $4.40-$4.55 to $4.48-$4.53 vs $4.47 Est; Narrows FY2025 Sales Guidance from $1.356B-$1.378B to $1.365B-$1.372B vs $1.368B Est
Conmed (NYSE:CNMD) narrows FY2025 Adj EPS guidance from $4.40-$4.55 to $4.48-$4.53 vs $4.47 analyst estimate. Narrows FY2025 sales outlook from $1.356 billion-$1.378 billion to $1.365 billion-$1.372 billion vs $1.368
11-06 05:29
Conmed Q3 Adj. EPS $1.08 Beats $1.05 Estimate, Sales $337.900M Beat $334.760M Estimate
Conmed (NYSE:CNMD) reported quarterly earnings of $1.08 per share which beat the analyst consensus estimate of $1.05 by 2.66 percent. This is a 2.86 percent increase over earnings of $1.05 per share from the same period
11-06 05:28
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
Conmed Appoints Kim Kelderman to Board of Directors
Conmed ( ($CNMD) ) just unveiled an update. On September 8, 2025, CONMED Corpor...
09-10 04:28
Piper Sandler Maintains Overweight on Conmed, Lowers Price Target to $68
Piper Sandler analyst Matt O'Brien maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $80 to $68.
07-31 21:55
